Thymosin Beta-4 (TB-500): Benefits, Mechanism & Research Guide
Thymosin Beta-4 (TB-4) is a naturally occurring 43-amino-acid peptide that regulates actin polymerization and drives tissue repair, wound healing, angiogenesis, and inflammation modulation. TB-500 is its synthetic active fragment, used in regenerative research for muscle, tendon, cardiac, dermal, and neural recovery.
Key Facts
- Name: Thymosin Beta-4 (TB-4, TB-500, Tβ4)
- Type: 43-amino-acid regenerative peptide
- Gene: TMSB4X (X-linked)
- Molecular weight: 4,963 Da
- Discovered: 1981 (isolated from bovine thymus)
- Primary function: G-actin sequestration, cytoskeletal regulation
- Status: Research use only; not FDA-approved; WADA-prohibited in sport
What is Thymosin Beta-4?
Thymosin Beta-4 is the most abundant member of the beta-thymosin family and is present in nearly every human and animal cell. It binds monomeric G-actin, regulating cytoskeletal dynamics that drive cell migration, wound healing, angiogenesis, and tissue regeneration. TB-500, a synthetic fragment of TB-4, replicates these regenerative effects and is widely used in preclinical studies.
Research-Backed Benefits
- Tissue and muscle repair — accelerates recovery in muscle, tendon, and ligament.
- Cardiovascular support — studied for cardiac repair after ischemic injury.
- Anti-inflammatory action — modulates inflammatory cytokines.
- Hair and skin renewal — stimulates stem cell migration in follicles and dermis.
- Neuroprotection — emerging evidence for neuronal survival and remyelination.
- Wound and corneal healing — reduces healing time via actin regulation and angiogenesis.
Mechanism of Action
- Actin sequestration — binds G-actin monomers, regulating filament assembly.
- Cell migration — mobilizes endothelial and progenitor cells to injury sites.
- Angiogenesis — stimulates new blood vessel formation.
- Anti-inflammatory modulation — downregulates pro-inflammatory cytokines.
- Stem cell recruitment — activates progenitor cells for cardiac, dermal, and follicular regeneration.
TB-4 vs TB-500: Comparison
| Property | Thymosin Beta-4 (TB-4) | TB-500 |
|---|---|---|
| Origin | Naturally occurring | Synthetic fragment |
| Length | 43 amino acids | ~7 amino acids (active region) |
| Cost to produce | Higher | Lower |
| Primary use | Clinical research | Preclinical research, recovery |
| Regenerative effect | Full spectrum | Mimics core healing activity |
Research Dosage Protocol
Common research literature references a loading phase of 2–2.5 mg twice weekly for 4–6 weeks, followed by maintenance dosing of 2 mg every 1–2 weeks. Administration is typically subcutaneous or intramuscular after reconstitution with bacteriostatic water. All use must be supervised in a research setting.
Safety and Side Effects
Reported observations include mild lethargy, transient head rush, and injection-site reactions. Long-term human safety data remains limited. TB-500 is banned by the World Anti-Doping Agency (WADA) for athletic competition.
Frequently Asked Questions
What is Thymosin Beta-4?
A 43-amino-acid peptide encoded by the TMSB4X gene that regulates actin and supports tissue repair, cell migration, and inflammation modulation.
What is the difference between TB-500 and Thymosin Beta-4?
TB-500 is a synthetic short fragment of the TB-4 active region. It mimics the regenerative properties of full-length TB-4 and is easier to manufacture.
Is Thymosin Beta-4 FDA-approved?
No. It is research-use-only. Multiple clinical trials are ongoing in dermal wound healing, dry eye, and cardiac repair.
What are the main benefits?
Wound healing, muscle/tendon repair, anti-inflammatory effects, cardiac regeneration, hair growth stimulation, and corneal healing.
What is the typical research dosage?
2–2.5 mg twice weekly for 4–6 weeks (loading), then 2 mg every 1–2 weeks (maintenance).
Are there side effects?
Mild lethargy, head rush, and injection-site reactions have been reported. Long-term human safety data is limited.
Is it legal?
Legal for research in most jurisdictions; not approved as a therapeutic; WADA-prohibited in competitive sport.
References
- Goldstein AL, et al. Thymosin beta-4: a multi-functional regenerative peptide. PubMed ID 22455565.
- Bock-Marquette I, et al. Thymosin beta-4 promotes cardiac repair. PubMed ID 15616553.
- Sosne G, et al. Thymosin beta-4 and the eye: wound healing. PubMed ID 22994766.
Educational research resource. Not medical advice. © ThymosinBeta.com.